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a  b  s  t  r  a  c  t
Vascular  early  response  gene  (Verge)  is a  novel  immediate  early  gene  that  is highly  expressed  during
developmental  angiogenesis  and  after  ischemic  insults  in  adult  brain.  However,  the  role  of  Verge  after
neonatal  injury  is not known.  In  the  present  study,  we investigated  the  hypothesis  that  Verge  contributes
to  vascular  remodeling  and  tissue  repair  after  neonatal  ischemic  injury.  The Rice–Vanucci  model  (RVM)
was  employed  to induce  neonatal  stroke  in  both  Verge  knockout  (KO)  and  wild-type  (WT)  postnatal  day
10  (P10)  mice.  Histological  and  behavioral  outcomes  at acute  (24 h), subacute  (7 days)  and  chronic  (30
days)  phases  were  evaluated.  Angiogenesis,  neurogenesis,  and  glial  scar  formation  were  also  examined  in
the  ischemic  brain.  No  signiﬁcant  differences  in  outcomes  were  found  between  WT  and  Verge  mice  at 24  heonate
eurogenesis
ascular early response gene
or 7 days  after  stroke.  However  genetic  deletion  of Verge  led  to pronounced  cystic  cavitation,  decreased
angiogenensis  and glial  scar  formation  in  the  ischemic  hemisphere  compared  to  WT  mice  at  30  days.
Verge  KO  mice also  had  signiﬁcantly  worse  functional  outcomes  at 30 days  which  was  accompanied  by
decreased  neurogenesis  and  angiogenesis  in  the  ischemic  hemisphere.  Our study  suggests  that  Verge
plays  an  important  role  in  the  induction  of  neurogenesis  and  angiogenesis  after  ischemia,  contributes  to
improved  tissue  repair,  and  enhances  chronic  functional  recovery.
© 201. Introduction
Perinatal arterial ischemic stroke (PAIS), with an incidence of
/2500 to 1/5000 term neonates, is an important cause of hemi-
legic cerebral palsy and cognitive impairment in children (Cheong
nd Cowan, 2009). The underlying pathophysiology of PAIS is dif-
cult to study in the human. It is critical to model neonatal stroke
n animals to identify and develop therapeutic strategies to reduce
rain injury in newborns with PAIS. Numerous experimental stud-
es have examined potential therapies for neonatal stroke ranging
rom anti-excitotoxic, anti-oxidative, and anti-apoptotic therapies
o stem cell replacement and hypothermia therapy (Kleman et al.,
Abbreviations: BrdU, 5-Bromo-2′-deoxyuridine; CD105, endoglin; CV, cresyl vio-
et; DAPI, dihydrochloride; KO, knockout; MCAO, middle cerebral artery occlusion;
euN, neuronal nuclear antigen; PAIS, perinatal arterial ischemic stroke; P10, post-
atal day 10; RVM, Rice–Vanucci model; TTC, triphenyltetrazolium chloride; Verge,
ascular early response gene; VWF, Von Willebrand factor; WT,  wild-type.
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2010). However, due to the complexity of the response to ischemic
injury in the brain at present no individual pharmacological agents
have been proven effective (Lai and Yang, 2011). Novel therapeu-
tic strategies are urgently needed for this devastating disease. The
active developmental state of the early postnatal brain provides
an exciting potential therapeutic opportunity, i.e. enhancement of
angiogenesis. Angiogenesis, especially in a relatively young brain,
could represent an effective way  to repair the injured brain tissue
and potentially lead to improved function and recovery. Impor-
tantly, discovering mechanisms by which repair can recapitulate
normal development may  have implications for adult brain injury
as well.
Vascular early response gene (Verge), a novel immediate early
gene (IEG), is expressed selectively in vascular endothelial cells
and platelets (Regard et al., 2004). Verge mRNA and protein are
rapidly and transiently induced in mature, quiescent vasculature
in adult; however, they are constitutively expressed at high lev-
els in the endothelium of developing tissues in association with
angiogenesis in neonatal animals (Regard et al., 2004). Verge
expression is responsive to local tissue conditions, as transient
focal ischemia induced a threefold increase in Verge mRNA expres-
Open access under CC BY-NC-SA license.sion in the ischemic hemisphere. Previous work has shown that
mice with Verge deletion develop normally, but exhibit reduced
edema formation after experimental stroke in adulthood, an effect
that was independent of infarct volumes (Liu et al., 2012c) which
cense.
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ere equivalent in Verge KO and WT  adult mice. In this study,
e utilized the RVM (Vannucci and Perlman, 1997) in Verge KO
nd WT  littermate mice to induce ischemia at post-natal day
0 (P10) to test the hypothesis that Verge activation increases
ngiogenesis and improves chronic recovery after neonatal
troke.
. Materials and methods
.1. Experimental animals
Verge KO (original breeding pairs from Johns Hopkins University
s a gift from Dr. Paul Worley) and WT  C57BL/6 littermates P10 mice
ere used. The sex ratio of mice was balanced by randomly putting
qual numbers of male and female pups in each cohort. This study
as conducted in accordance with NIH guidelines for the care and
se of animals in research and under protocols approved by the
nimal Care and Use Committee of the University of Connecticut
ealth Center.
.2. RVM model
The RVM was modiﬁed for use in mice (Knox et al., 2013). Brieﬂy,
10 mice were anaesthetized with 1.5% Isoﬂurane and placed in the
upine position. Body temperature was maintained at 36.5 ◦C with
n automated temperature control feedback system. The fur and
kin of the frontal neck region were disinfected with 70% ethanol,
nd then a less than 0.5 cm long midline incision was made to
xpose the right common carotid artery (CCA). Double permanent
igation of CCA was made with 6–0 silk suture, and then the incision
as closed and the pups were returned to their dams. Sham mice
nderwent the same procedure except ligation of the right CCA. 1 h
fter surgery, pups were placed in a 36 ◦C chamber containing 10%
xygen and 90% nitrogen for 45 min, 60 min  or 90 min  to induce
schemic injury. Mice were sacriﬁced 24 h (acute), 7 days (suba-
ute), or 30 days (chronic) after stroke. Pups in the 30-day survival
ohort were injected with 5-Bromo-2′-deoxyuridine (BrdU, Milli-
ore) (100 mg/kg) i.p. twice a week after VRM modeling (Bartley
t al., 2005). The corner test was performed by an investigator
linded to stroke/sham and genotype at 7 days and 30 days after
troke; the score of corner test was determined by the number of
ight turn/right plus left turns as previously described (Li et al.,
004).
.3. Histological assessment
The infarct was quantiﬁed at both the acute and subacute end-
oints by triphenyltetrazolium chloride (TTC) staining (Liu et al.,
009); brain atrophy was quantiﬁed at chronic endpoints stroke
ith cresyl violet (CV) staining as in (Liu et al., 2012a). Brain infarct
olume (acute) or tissue loss (subacute and chronic endpoints) was
alculated as previously described (Liu et al., 2009, 2012a). Hemi-
pheric cyst formation was examined when brains were taken out
f the skulls and conﬁrmed by TTC or CV staining.
.4. Immunohistochemistry
Pups were sacriﬁced at 7 days or 30 days after stroke; brains
ere perfused (Liu et al., 2012a) and stained with 4′,6-diamidino-2-
henylindole dihydrochloride (DAPI, 1:1000, Invitrogen) for nuclei,
erge antibody (obtained as a gift from Dr. Paul Worley in John
opkins University, 1:100) for Verge expression in the vessel,
ndoglin (CD105, 1:20, Dako) and Von Willebrand factor (VWF,
:100, Santa-Cruz) for angiogenesis (Starke et al., 2011; Tan et al.,
013), anti-BrdU (1:20, Sigma–Aldrich) was used to identify new-
orn cells (Biron et al., 2011), anti-NeuN for neurons (Liu et al.,ulletin 98 (2013) 111– 121
2009), and glial ﬁbrillary acidic protein (GFAP, 1:200, Dako) for glial
scar formation (Bao et al., 2012). Secondary antibodies used were
Alexa Fluor dyes 488 and 594 (1:1000, Invotrogen), complemen-
tary to the species of primary antibodies. The signal was  visualized
with a Zeiss Axiovert 200M microscope (Carl Zeiss) and captured
with Zeiss LSM510 Meta software (Liu et al., 2012b). The ﬂuorescent
intensity of the signal was analyzed by ImageJ software (NIH).
2.5. Statistical analysis
Investigators were blinded to mouse genotype and treatment
(sham vs. stroke) for all experiments. Mice with abnormal body
weights and behavior (e.g. body shaking, limp, etc.) before VRM
were excluded. Data from individual experiments were presented
as Mean ± SEM and analyzed with t-test for two groups, and two-
way ANOVA for multiple group comparison. The hemispheric cyst
formation data was  presented as the count of cysts/total count of
samples in the group and analyzed with Fisher’s Exact Test. P < 0.05
was considered statistically signiﬁcant for all data.
3. Results
3.1. Acute and subacute outcomes of 90-min neonatal stroke
Brain injury varies in the mouse RVM depending on the time
exposed to 10% oxygen with a range from 15 min (Jiang et al., 2008)
to 2.5 h (Nakanishi et al., 2009) reported in the literature. We chose
the median time (90 min) at the beginning of this study. 24 h after
a 90 min  10% oxygen exposure, visible infarct was seen in the right
(ipsilateral) hemisphere in both WT  and KO pups (Fig. 1A-i); how-
ever, quantitative analysis revealed no difference in infarct volumes
between the two strains (Fig. 1A-ii). Next we  extended the survival
time to 7 days to examine subacute stroke outcomes. Stroke mice
of both strains had a signiﬁcant preference in the corner test com-
pared to sham mice. Surprisingly, we  found signiﬁcantly more gross
hemispheric cyst formation in KO brains compared to WT mice (KO
vs. WT:  6/6 vs. 2/7; P = 0.02) (Fig. 1B-i and ii); however quantiﬁca-
tion of either tissue loss (Fig. 1B-iii) or behavioral deﬁcits in the
corner test (Fig. 1B-iv) revealed no differences between genotypes.
3.2. Angiogenesis and glial scar formation after 7 days of 90 min
neonatal stroke
Surprised by the distinct phenotype of hemispheric cyst for-
mation seen in Verge KO mice after 7 days of 90 min  stroke, we
hypothesized Verge may  have a role in promoting post-stroke
angiogenesis which can prevent cavitation in the ischemic injury
(Leker et al., 2009). CD105 is an important marker for angiogenesis
(Duff et al., 2003). We  performed triple labeling of brain slices with
CD105, Verge, and DAPI. Consistent with our previous ﬁndings in
adult mice, Verge expression was increased after stroke in WT  pups
(Fig. 2B and D). Verge also co-localized with CD105 (Fig. 2B). Stroke
induced a signiﬁcant increase in CD105 expression only in WT  mice,
and KO pups expressed signiﬁcantly less CD105 compared with
their WT  counterparts (Fig. 2B and C). The decreased angiogenesis
in KO vs. WT  brains after ischemia was further conﬁrmed by VWF
staining (Fig. 2E).
Glial scars formed early in the ischemic brain have a beneﬁ-
cial role in curbing ischemic lesion (Beck et al., 2008). We  used
GFAP staining to identify glial scars and found dispersed, tangled
GFAP positive signals in both WT  and KO ipsilateral hemispheres
(Fig. 2F). WT  pups had signiﬁcantly denser glial scars than KO pups
(Fig. 2F and G). The astrocytes comprising the scar exhibited acti-
vated morphology of plump cell bodies and short processes (Fig. 2F:
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Fig. 1. Stroke outcomes in Verge KO and WT P10 mice subjected to 90-min stroke (RVM) followed by 24-h and 7-day survival. (A) Stroke outcomes in the 90 min stroke
plus  24 h survival cohort. (A-i) Representative coronal brain sections of TTC staining: white dotted line shows the midline of the brain; black dotted line illustrates the
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0  min stroke plus 7 days survival cohort. (B-i) Gross examination of the cyst in the i
B-ii)  Representative coronal brain sections of TTC staining. (B-iii) Quantiﬁcation o
*P  > 0.05. (For interpretation of the references to color in this ﬁgure legend, the rea
he insert). In sham mice, only a few GFAP positive astrocytes were
een near the edge of the cortex.
.3. Acute and subacute outcomes after 60-min neonatal
schemia
To exclude the possibility that the 90 min  ischemic insult was
oo severe to reveal any difference in stroke outcomes between KO
nd WT  pups due to the “ceiling effect”, we shortened the ischemic
ime to 60 min. Again, 24 h after stroke, no difference in infarct vol-
mes was seen between the two cohorts (Fig. 3A); signiﬁcantly
ore hemispheric cyst formation was seen in KO vs. WT brains
fter 7 days of stroke (KO vs. WT:  5/6 vs. 0/7; P = 0.004) (Fig. 3B-i),
ut similar to what was seen with a 90 min  insult, there was no
igniﬁcant difference in tissue loss (Fig. 3B-ii) or in the results of
orner testing (Fig. 3B-iii) between KO and WT  pups. We  furthere. (A-ii) quantiﬁcation of infarct volumes; n = 6/group. (B) Stroke outcomes in the
ic hemisphere: the white arrow indicates the cyst in the KO ipsilateral hemisphere.
ct volumes; n = 7 in WT group; n = 6, KO. (B-iv) Scores of Corner test; *P < 0.05 and
 referred to the web  version of the article.)
reduced the stroke time to 45 min  in our model, but the infarct at
day 7 was  almost undetectable and non-measurable in most of the
brains, and no difference in corner test scores was seen between
sham and stroke mice (data not shown).
3.4. Chronic outcomes of 60-min neonatal stroke
The phenotype of hemispheric cyst development in KO pups was
striking. We  hypothesized that these early cysts may  be important
to more chronic functional and histological outcomes. Therefore
another cohort of pups was examined that were subjected to a
60 min  ischemic challenge and allowed to survive for 30 days. His-
tological assessment showed that the majority of KO brains (5/7)
had visible cyst formation; however, the cavity was only seen in
one WT  brain (1/8). Evident atrophy was  seen in the ipsilateral
hemisphere of both KO and WT  mice as indicated by an enlarged
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psilateral ventricle due to volume loss (Fig. 4A). Since atrophy
ould conceal the presence of a previously formed cavity, statistical
nalysis of cavity formation is not applicable for this chronic cohort.
he quantitative analysis of remaining tissue in the ischemic brain
howed that KO pups had signiﬁcantly more ipsilateral tissue loss
han WT  mice (Fig. 4B). Correspondingly, KO mice had signiﬁcantly
igher corner test scores than their WT  counterparts (Fig. 4C).
ig. 2. Angiogenesis and glial scar formation in the cohort of 90 min  stroke plus 7 days s
f  interest to do the immunoﬂuorescent staining. (B) Representative pictures (20×) of 
cale  bar = 50 m.  (C) Quantiﬁcation of CD105 ﬂuorescent intensity. *P < 0.05, **P < 0.01;
 = 6/group. (E) Representative pictures (20×) of VWF  antibody staining in KO and WT ips
API  staining in KO and WT ipsilateral hemispheres; scale bar = 50 m.  In the GFAP/WT p
rrow.  (G) Quantiﬁcation of GFAP ﬂuorescent intensity. *P < 0.05 vs. WT group; n = 6/grouulletin 98 (2013) 111– 121
3.5. Angiogenesis, neurogenesis, and glial scar formation assessed
at a chronic endpoint after neonatal stroke
Next we  examined CD105 and Verge expression at 30 days after
a 60 min  stroke. Surprisingly increased expression of Verge after
stroke persisted at 30 days (Fig. 5A and C), accompanied by the
same pattern of CD105 expression (Fig. 5A and B). Similar to the
urvival. (A) The black box in a TTC-stained coronal brain section indicates the area
CD105, Verge antibody and DAPI staining in KO and WT ipsilateral hemispheres;
 n = 6/group. (D) Quantiﬁcation of Verge ﬂuorescent intensity. *P < 0.05 vs. sham;
ilateral hemispheres; scale bar = 50 m.  (F) Representative pictures (10×) of GFAP,
icture, the insert box (100×) indicates the same astrocyte as the one pointed by the
p.
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arly time points (Fig. 2B), CD105 positive vessels also expressed
erge, suggesting a supportive role for Verge in angiogenesis. The
ecreased angiogenesis in KO vs. WT  brains after ischemia was fur-
her conﬁrmed by VWF  staining (Fig. 2D). It has been demonstrated
hat increased angiogenesis leads to enhancement of neurogenesisnued ).
(Jin et al., 2002; Taguchi et al., 2004; Wang et al., 2004; Zhang et al.,
2003). In order to determine whether Verge also has an impact on
neurogenesis post-ischemia, we  injected both WT and KO mice in
the chronic endpoint cohort with BrdU to examine the new-born
cells. WT  pups had signiﬁcantly more BrdU positive cells in the
116 M.A. Mirza et al. / Brain Research Bulletin 98 (2013) 111– 121
Fig. 3. Stroke outcomes from the cohort of 60 min  stroke + 24 h/7 days survival. (A) Total infarct volumes show no signiﬁcant difference between KO and WT  mice of 60 min
stroke  + 24 h survival cohort; n = 7/group. (B) Outcomes from the cohort of 60 min stroke + 7 days survival. (B-i) Representative coronal brain sections of TTC staining; (B-ii)
quantiﬁcation of infarct volumes showed no difference between KO and WT mice, n = 7 (WT), n = 6 (KO). (B-iii) Scores of Corner test; *P < 0.05 and **P > 0.05.
Fig. 4. Chronic stroke outcomes from the cohort of 60 min  stroke + 30 days survival. (A) Representative coronal brain sections of CV staining. The right ventricles of both WT
and  KO mice are larger compared to the left. In the WT brain, the right striatum and cortex are smaller than the ones on the left; there is cavity formation in the ipsilateral
hemisphere of the KO brain. (B) Tissue loss in ipsilateral hemispheres of WT and KO mice. *P < 0.05 vs. KO group; n = 8(WT), n = 7(KO). (C) Scores of Corner test 30 days after
60  min  stroke. *P < 0.05.
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Fig. 5. Angiogenesis, neurogenesis, and glial scar formation in the cohort of 60 min  stroke + 30 days survival. (A) Representative pictures (20×) of CD105, Verge antibody and
DAPI  staining in KO and WT ipsilateral hemispheres; scale bar = 50 m.  (B) Quantiﬁcation of CD105 ﬂuorescent intensity. *P < 0.05; n = 8(WT), n = 7(KO). (C) Quantiﬁcation
of  Verge ﬂuorescent intensity. *P < 0.05 vs. sham; n = 8/group. (D) Representative pictures (20×) of VWF  antibody staining in KO and WT ipsilateral hemispheres; scale
bar  = 50 m.  (E) Representative pictures (20×) of CD105 and BrdU staining; scale bar = 50 m.  (F) Quantiﬁcation of BrdU ﬂuorescent intensity; *P < 0.05; n = 8(WT), n = 7(KO).
(G)  Representative pictures (20×) of BrdU and NeuN double staining in KO and WT ipsilateral hemispheres; scale bar = 50 m. (H) Representative pictures (10×) of GFAP,
DAPI  staining in KO and WT ipsilateral hemispheres; scale bar = 50 m.  In GFAP/WT picture, the insert box (100×) indicates the same astrocyte as the one pointed by the
arrow. In the DAPI/KO picture, the arrow indicates the area of no DAPI signals.
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psilateral hemisphere than KO mice (Fig. 5E and F). Almost all
D105 positive vessels were co-labeled with BrdU, indicating the
resence of post-stroke angiogenesis. We  also performed double
taining with BrdU and NeuN, and found WT  brains had more
o-localized signals than KO brains 30 days after ischemia (Fig. 5G).
inally we examined chronic glial scar formation in the ipsilateral
emisphere of both WT  and KO pups. Surprisingly a very distinct
henotype of chronic glial scar formation was observed between
he two strains (Fig. 5H). In WT  brains, dispersed GFAP signals were
till seen in the ipsilataral hemisphere, although the astrocytes
xhibited smaller bodies and ﬁner processes (Fig. 5H: the insert)
ompared to those in early phase of stroke (Fig. 2F: the insert).
owever, very dense and thick GFAP signals were seen along
he cavity wall in which DAPI staining was absent or attenuated,nued ).
suggesting most of these GFAP signals are protein deposition
(“aged” scars) rather than astrocytes.
4. Discussion
Verge is an important IEG whose function remains unclear.
Verge is very highly expressed in the vasculature and in platelets
during development and is important in angiogenesis (Regard et al.,
2004). We have previously shown that Verge is induced by stroke
in the adult brain. However, as this is a developmentally regu-
lated gene, and is only highly-expressed in select vessels after an
ischemic injury in adulthood (Regard et al., 2004), we hypothe-
sized that Verge may  have a greater impact after a developmentally
induced injury such as perinatal stroke. The present study is the
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(Conti
ﬁ
t
a
b
d
(
e
V
V
n
c
s
s
i
s
c
G
n
b
f
s
i
o
eFig. 5. 
rst report of the effects of loss of Verge, after ischemic injury in
he neonatal brain. Several important results were found. Firstly,
cute and subacute stroke outcomes, both histological (infarct) and
ehavioral (corner turning preference) were not affected by Verge
eletion. This is consistent with our previous study in adult animals
Liu et al., 2012c). However, loss of Verge led to signiﬁcant differ-
nces in chronic outcome after an ischemic injury, suggesting that
erge signaling is important in stroke recovery. Secondly, loss of
erge led to a dramatic increase in ipsilateral cyst formation in the
eonatal brain. Stroke-induced cyst formation was seen at suba-
ute stage of ischemia (7 days), and was still evident 30 days after
troke in Verge KO mice. This was related to a reduction in both tis-
ue repair and functional recovery. Thirdly, a signiﬁcant difference
n glial scar formation was found in WT  versus KO pups. At an early
tage post-ischemia, enhanced glial scar formation was  seen in WT
ompared to KO brains; however, KO but not WT  brains exhibited
FAP deposition along the cyst wall at chronic endpoints. Finally,
eurogenesis and angiogenesis were compromised in the ischemic
rain of Verge KO mice, which was closely related to the glial scar
ormation and stroke outcomes.
A previous study examined the role of Verge in experimental
troke induced by 90 min  middle cerebral artery occlusion (MCAO)
n adult mice and found loss of Verge did not affect acute stroke
utcomes (i.e., infarct size) (Liu et al., 2012c). The lack of acute
ffects of Verge deletion extends to neonates as shown in this study.nued ).
Infarct volumes early after stroke were measured by TTC staining,
a marker of tissue dehydrogenase and mitochondrial dysfunction
that occurs in both the core and penumbra (Benedek et al., 2006;
Tureyen et al., 2004). The pathology of the penumbra is traditionally
considered as a one-dimensional, linear progression from initial
injury to ﬁnal infarct; however it is now apparent that the penum-
bra may  not passively die over time, but can also actively recover
(Lo, 2008a,b). Therefore, outcomes at the early stage of stroke tend
to be severer than that of the recovery stage, a time when neu-
rological deﬁcits reﬂect more closely the size and location of the
structural lesion that is much smaller than the previous combina-
tion of core and penumbra (Liu et al., 2009). The dynamic progress
of infarct typically occurs over a few days in ischemic brains of
WT mice; however, in brains of Verge KO mice, the ischemic tis-
sue developed much quicker and more completely into the core,
and was more likely to form necrotic cyst. Interestingly these early
differences were not reﬂected in either behavioral or histological
assessments of tissue injury, however the lack of post-stroke angio-
genesis at even 7 days of injury set the stage for cyst formation, later
enhanced tissue loss, and poorer functional outcomes.
Our data provide mechanistic clues as to why KO pups develop
more cystic cavitation after injury and resultantly lose more tissue
in the ischemic hemisphere than WT mice at 30 days. Verge expres-
sion was  signiﬁcantly increased in the ipsilateral hemisphere at
both early and chronic stages of ischemia, and this was  associated
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ith up-regulated expression of CD105 and VWF, increased glial
car formation (GFAP), and an enhancement in the number of BrdU
nd NeuN positive cells. These data suggest that active angiogen-
sis and neurogenesis occurs in WT  ischemic brains after neonatal
njury that is impaired in Verge KO mice. Verge has the potential
o induce angiogenesis and thus improved formation of the neu-
ogenic niche (Young et al., 2011). This may  keep the penumbral
rea active in cell proliferation and tissue repair. In cell culture
odels using rat brain endothelial cells that express Verge, treat-
ent with phorbol 12-myristate 13-acetate, a potent inducer of
erge expression, led to a reorganization of the actin cytoskele-
on and the formation of paracellular gaps (Regard et al., 2004),
uggesting a positive role for Verge in tissue repair. Neurogene-
is and angiogenesis start to occur days after stroke (Lanfranconi
t al., 2011) and have an effect in reducing necrotic cavity formation
Leker et al., 2009; Ohta et al., 2004; Osaka et al., 2010). Knockout of
erge suppresses angiogenesis so much so that ischemia could not
ven induce a signiﬁcant increase in CD105 expression compared
o Verge KO sham mice (Fig. 2B and C), probably due to the “ﬂoor
ffect”.
Glial scar formation may  also have a protective effect early after
schemic injury in the brain. The glial scar protects healthy brain
reas from exposure to toxic substances and cellular debris in the
njured tissue, repairs the BBB, and prevents an excessive hyper-
nﬂammatory response to the infarct (Beck et al., 2008; Kahle and
ix, 2013; Li et al., 2005). Therefore, glial scar formation early after
troke can help isolate injured tissue and limit necrotic cyst forma-
ion. The beneﬁcial effects of glial scar formation correlated with
he occurrence of necrotic cysts 7 days after neonatal injury. How-
ver, in the chronic phase of ischemic injury, the glial scar becomes
 physical and chemical detriment to repair (Silver and Miller, 2004;
iu and He, 2006). This was  also reﬂected in the appearance of the
lial scars 30 days after stroke, which were thicker, more disor-
anized and ﬁbrillary along the cyst wall. This appears to form a
echanical obstacle to angiogenesis and neurogensis. Glial scar
as also apparent in WT ischemic brains at chronic endpoints,
ut the morphology was very distinct from that of KO mice. The
car consists of quiescent astrocytes with smaller bodies and ﬁner
rocesses compared to those seen at early stage of ischemia. It is
ossible that this early scar in WT  brains provides a tissue “scaffold”
or angiogenesis and neurogenesis. When Verge is absent, less glial
car was formed in the early phase of ischemia and the scar that
ppears later after injury is likely detrimental in the chronic phase.
There are several caveats that need to be recognized when inter-
reting this data. We  only compared the ischemic responses of
erge KO to WT  by examining the effects of loss of Verge. Whether
nhancement of Verge signaling has any effect on either ischemic
amage or recovery is unknown and awaits future studies. We
nly examined angiogenesis and glial scar formation at 7 days and
0 days after ischemia; therefore how the tissue in the ischemic
rain evolved between these two time points is unknown. The third
aveat is that although we examined chronic recovery at 30 days,
his is still not long enough to examine the effect of neonatal stroke
nd Verge manipulation on adult behavioral recovery, as these 40
ay animals are considered “adolescent” (Harrison, 2011). How-
ver, it is most likely that the changes that were seen at 30 days
ould persist into adulthood with WT  mice continuing to improve,
nd continued deﬁcits in the KO mice. The cavitation seen in the KO
rains 30 days after stroke is likely permanent and not amenable
o repair. Finally, since the sex of animals was equally balanced in
he present study, we cannot conclude if there was an effect of sex
n either stroke outcomes or on angiogenesis or neurogenesis. The
ffect of Verge on neonatal stroke merits further investigation.
In summary, Verge KO mice develop more hemispheric cyst
ormation compared to their WT counterparts when subjected to
schemia. This was related to a signiﬁcantly diminished level ofulletin 98 (2013) 111– 121
angiogenesis/neurogenesis in the KO mice. Loss of Verge led to
a decrease in early (7 day) glial scar formation, which was more
robust in WT  mice. However at 30 days, the scar was  more dysmor-
phic, thicker and disorganized in the KO mice, which was correlated
with cyst formation, tissue loss, and poorer behavioral outcomes.
Knockout of Verge had no effect on acute and subacute stroke out-
comes (as measured by infarct volumes); however, stroke recovery
at more chronic stages is strikingly compromised in KO mice. Verge
activation promotes neurogenesis and angiogenesis after ischemia,
and enhances chronic stroke recovery, suggesting that investigat-
ing Verge signaling may  have translational potential.
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